Viracta Therapeutics (VIRX)
(Delayed Data from NSDQ)
$0.65 USD
+0.03 (5.18%)
Updated Jun 12, 2024 03:57 PM ET
After-Market: $0.64 -0.01 (-1.54%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 34% (84 out of 249)Zacks Sector Rank
Top 50% (8 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.25 | 1.52 | 9.99 |
Current Quarter Estimate | -0.35 | -2.04 | 57.00 |
Year Ago Quarter Estimate | -0.32 | -0.59 | 52.54 |
Next Quarter Estimate | -0.29 | -2.00 | 61.00 |
Next Year Estimate | -1.19 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 8.33 | 14.30 | 15.67 |
Next Year | 1.65 | 14.00 | 9.31 |
Last 5 Years | NA | 6.90 | 8.10 |
Next 5 Years | NA | 24.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 4.31 | 1.83 |
Price/Cash Flow (MRFY) | NA | 8.08 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -68.51% |
Return on Equity (TTM) | -244.68% | -59.74% |
Debt to Equity (MRQ) | 0.00 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.